meta_pixel
Tapesearch Logo
Log in
The People's Pharmacy

Show 1420: The Cooking Oil Controversy Spotlights Cancer

The People's Pharmacy

Joe and Terry Graedon

Health & Fitness, Medicine, Kids & Family, Alternative Health

4.5934 Ratings

🗓️ 26 February 2025

⏱️ 77 minutes

🧾️ Download transcript

Summary

This week, we dig into the cooking oil controversy. For decades, we’ve heard that we should be using vegetable oils rather than butter, lard or other fats (possibly even olive oil). Oils from corn, soybeans, sunflower or safflower seeds are rich in polyunsaturated fatty acids. Consequently, people consuming them may have lower cholesterol levels than […]

Transcript

Click on a timestamp to play from that location

0:00.0

I'm Joe Graydon. And I'm Terry Graydon. Welcome to this podcast of the People's Pharmacy.

0:06.0

You can find previous podcasts and more information on a range of health topics at People's Pharmacy.com.

0:15.3

Inexpensive cooking oils from corn, peanut, soy, or sunflower seeds are popular.

0:23.4

Are they as healthy as people think?

0:27.8

This is the People's Pharmacy with Terry and Joe Graydon.

0:41.7

For decades, Americans were urged to trade in their butter and even olive oil for polyunsaturated vegetable oils.

0:49.8

Is there an unexpected downside for consuming so much omega-6 fatty acids relative to omega-3 fats?

0:56.9

Recent research links high omega-6 consumption to a higher risk of certain cancers.

1:02.6

We'll talk with two scientists about the links between seed oils and prostate and colorectal cancer. Coming up on the people's pharmacy, the cooking oil controversy, spotlightlights Cancer.

1:20.3

In the People's Pharmacy Health Headlines, COVID cases have been trending down for the last several weeks, but hundreds of people are still dying. Paxlovod has been promoted as a

1:25.8

life-saving treatment, especially for older people.

1:29.2

A new study in JAMA utilized data from Ontario, Canada, to find out whether Paxlovod reduced hospitalizations and deaths.

1:38.6

Ontario records in 2022 provided a natural experiment because during that time, the province restricted Paxlovod to those over 70 with a positive COVID-19 test.

1:52.0

Comparing those just under the cutoff age to those just over it allowed for a comparison between Paxlovit treatment and a control group.

2:02.6

The vast majority of older Ontarians had received at least two COVID shots by that time. Although the rate of Paxlovit

2:08.4

prescriptions was twice as high for people over 70, there were no significant differences in

2:15.1

hospitalization or mortality rates.

2:18.1

Tens of millions of people take SSRI and SNRI-type antidepressants on a regular basis.

2:25.3

A large analysis from Sweden raises crucial questions about a possible link between such

2:31.1

medications and cognitive decline. Over 18,000 older patients with a diagnosis of

2:37.6

dementia were tracked for up to 11 years. The average follow-up was just over four years. All were

2:44.0

part of the Swedish registry for cognitive dementia disorders. The authors found that those taking

...

Please login to see the full transcript.

Disclaimer: The podcast and artwork embedded on this page are from Joe and Terry Graedon, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of Joe and Terry Graedon and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.

Copyright © Tapesearch 2025.